Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-blinded, Propofol-controlled, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of HSK3486 Injectable Emulsion for Induction of General Anesthesia in Adults Undergoing Elective Surgery

NCT05478174 is registered in ClinicalTrials.gov with Haisco-USA Pharmaceuticals, Inc. as lead sponsor.

NCT NCT05478174
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05478174 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-blinded, Propofol-controlled, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of HSK3486 Injectable Emulsion for Induction of General Anesthesia in Adults Undergoing Elective Surgery
Lead sponsor
Haisco-USA Pharmaceuticals, Inc.
Phase
Phase 3
Overall status
Completed
Start date
July 26, 2022
Completion date
November 14, 2023
Enrollment
400 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

general anesthesia